ABOUT US Overview Milestones Accolades Board Of Directors History Social Responsibility BUSINESS Domestic :- - Marketing Divisions - In-Licensing International :- - APIs - FDFs FACILITIES R & D Centre API Plants Formulation Plants :- - Goa Plant I - Goa Plant II - Baddi - Waluj R & D Profile Functional Areas Pilot Plant PRODUCTS APIs Formulations INVESTORS Financials Annual Reports Presentations Analyst Reports Con Call Transcripts Stock Price From CMD's Desk Shareholding Pattern Corporate Policies Investor Grievances NEWSROOM Press Releases Indoco In News Industry News HR VALUES  Financial & IR Update  News Update  Downloads   Indoco records 1127 % Q3 growth in PAT Unaudited Financial Results - Q3 FY10 MDA Notes - Q3 FY10 Concall Transcript - Q3 FY10 Angel Securities Report - Q3 FY10   Indoco Remedies Licenses Out Technology to Watson Pharmaceuticals Inc. USA Indoco Remedies net at Rs 7.73 cr in Q3 Indoco eyes US, Europe markets; will sign four contract research treaties soon more »